Dividend Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 16:35:45 09/12/2025 GMT			5-day change	1st Jan Change
118.02 ^EUR	-1.03%		+0.73%	-15.94%

12-08	MERCK KGAA : Gets a Buy rating from JP Morgan	ZD
12-03	Merck KGaA Rebounds Sharply as Exane Drops Skepticism and Issues Positive Recommendation	DP

EPS & Dividend: Merck KGaA

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Dividend per Share ²	1.4	1.85	2.2	2.2	2.2	2.298	2.43	2.51
Rate of return	1%	0.81%	1.22%	1.53%	1.57%	1.93%	2.04%	2.11%
EPS ²	4.57	7.03	7.65	6.49	6.39	6.581	6.649	7.546
Distribution rate	30.6%	26.3%	28.8%	33.9%	34.4%	34.9%	36.5%	33.3%
Reference price ²	140.35	227.00	180.90	144.10	139.90	119.10	119.10	119.10
Nbr of stocks (in thousands)	434,778	434,778	434,778	434,778	434,778	434,778	-	-
Announcement Date	04/03/21	03/03/22	02/03/23	07/03/24	06/03/25	-	-	-

¹EUR in Million²EUR

Estimates

Past dividends: Merck KGaA

27/04/2025	Annual 2.2 EUR
28/04/2024	Annual 2.2 EUR
01/05/2023	Annual 2.2 EUR
24/04/2022	Annual 1.85 EUR
25/04/2021	Annual 1.4 EUR
28/05/2020	Annual 1.3 EUR
28/04/2019	Annual 1.25 EUR
29/04/2018	Annual 1.25 EUR
01/05/2017	Annual 1.2 EUR
01/05/2016	Annual 1.05 EUR

Upcoming events: Merck KGaA

05/01/2026	Consumer Electronics Show
05/03/2026 06:00	Q4 2025 Earnings Release
05/03/2026 13:00	Q4 2025 Earnings Call
23/04/2026	Annual General Meeting
13/05/2026 06:00	Q1 2026 Earnings Release
13/05/2026 13:00	Q1 2026 Earnings Call
06/08/2026 06:00	Q2 2026 Earnings Release
06/08/2026 13:00	Q2 2026 Earnings Call
11/11/2026	Q3 2026 Earnings Call
12/11/2026 06:00	Q3 2026 Earnings Release
10/03/2027	Q4 2026 Earnings Release (Projected)
19/05/2027	Q1 2027 Earnings Release (Projected)
04/08/2027	Q2 2027 Earnings Release (Projected)
17/11/2027	Q3 2027 Earnings Release (Projected)

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (N)	Dividend Yield (N+1)	P/E (N)	Price to Book (N)	EV / Sales (N)
	MERCK KGAA	1.93%	2.04%	18.1x	1.62x	2.83x
	KYOWA KIRIN CO., LTD.	2.38%	2.41%	23.71x	1.51x	2.31x
	HALOZYME THERAPEUTICS, INC.	-	-	11.61x	10.36x	6.05x
	SK BIOPHARMACEUTICALS CO., LTD.	-.--%	0.08%	58.65x	14.45x	14.26x
	YUHAN CORPORATION	0.43%	0.44%	72.54x	4.22x	3.82x
	INDIVIOR PLC	-.--%	-.--%	20.8x	-228.75x	3.76x
	BETTA PHARMACEUTICALS CO., LTD.	0.75%	0.95%	35.57x	3.3x	6.04x
	SUPERNUS PHARMACEUTICALS, INC.	-	-	-60.98x	-	-
	SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-	-	-	-	-
	SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-	-	-	-	-
	Average	0.91%	0.99%	22.50x	-27.61x	5.58x
	Weighted average by Cap.	1.58%	1.67%	22.71x	-7.48x	4.07x

See all sector dividends

Year-on-year evolution of the Yield

Dividend / Share (DPS) - Evolution of Analysts' Estimates

More analyst reviews

Dividend / Share (DPS) - Estimates Revisions

More analyst reviews

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

More analyst reviews

Annual Profit -

Company calendar

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

The best tools reserved for subscribers to boost the performance of your investments!